Briana Carol Ann Prager, M.D.,Ph.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 27 | 2023 | 1341 | 2.320 |
Why?
|
| Glioblastoma | 33 | 2023 | 3453 | 2.240 |
Why?
|
| Brain Neoplasms | 24 | 2023 | 8832 | 1.040 |
Why?
|
| Tumor Microenvironment | 6 | 2022 | 3694 | 0.530 |
Why?
|
| Epigenomics | 2 | 2020 | 910 | 0.510 |
Why?
|
| Meningioma | 2 | 2022 | 1203 | 0.500 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 1494 | 0.450 |
Why?
|
| Blood-Brain Barrier | 2 | 2021 | 1007 | 0.450 |
Why?
|
| Sphingosine | 1 | 2015 | 308 | 0.430 |
Why?
|
| Lysophospholipids | 1 | 2015 | 339 | 0.420 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 1710 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-myc | 5 | 2021 | 982 | 0.370 |
Why?
|
| Neural Stem Cells | 5 | 2022 | 865 | 0.310 |
Why?
|
| Health Surveys | 1 | 2017 | 3962 | 0.290 |
Why?
|
| Cell Line, Tumor | 19 | 2023 | 16657 | 0.280 |
Why?
|
| Multiple Sclerosis | 2 | 2017 | 3132 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2022 | 8355 | 0.240 |
Why?
|
| RNA-Binding Proteins | 3 | 2022 | 1885 | 0.230 |
Why?
|
| Signal Transduction | 9 | 2023 | 23112 | 0.230 |
Why?
|
| Molecular Targeted Therapy | 3 | 2020 | 2779 | 0.220 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3954 | 0.220 |
Why?
|
| Adenosine | 3 | 2023 | 819 | 0.210 |
Why?
|
| Organoids | 2 | 2021 | 711 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2021 | 460 | 0.210 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2022 | 41 | 0.200 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1328 | 0.200 |
Why?
|
| Methyltransferases | 2 | 2022 | 369 | 0.200 |
Why?
|
| Transcription Factors | 5 | 2022 | 12039 | 0.190 |
Why?
|
| Cell Proliferation | 13 | 2023 | 10300 | 0.190 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2020 | 47 | 0.180 |
Why?
|
| CREB-Binding Protein | 1 | 2020 | 147 | 0.180 |
Why?
|
| Drug Repositioning | 1 | 2021 | 229 | 0.170 |
Why?
|
| E2F3 Transcription Factor | 1 | 2019 | 36 | 0.170 |
Why?
|
| Glioma | 3 | 2023 | 3373 | 0.170 |
Why?
|
| Entropy | 1 | 2020 | 207 | 0.170 |
Why?
|
| CLOCK Proteins | 1 | 2019 | 85 | 0.170 |
Why?
|
| ARNTL Transcription Factors | 1 | 2019 | 92 | 0.160 |
Why?
|
| Epigenesis, Genetic | 6 | 2022 | 3655 | 0.160 |
Why?
|
| Nuclear Proteins | 3 | 2021 | 5746 | 0.150 |
Why?
|
| Bacteriophages | 1 | 2021 | 366 | 0.150 |
Why?
|
| Fluoxetine | 1 | 2021 | 738 | 0.150 |
Why?
|
| Mevalonic Acid | 1 | 2017 | 45 | 0.150 |
Why?
|
| Cell Hypoxia | 2 | 2018 | 659 | 0.140 |
Why?
|
| Morbidity | 1 | 2022 | 1743 | 0.140 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 344 | 0.140 |
Why?
|
| Mice | 20 | 2023 | 80087 | 0.140 |
Why?
|
| Animals | 23 | 2023 | 166331 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 7571 | 0.130 |
Why?
|
| Ependymoma | 1 | 2017 | 319 | 0.120 |
Why?
|
| Humans | 42 | 2023 | 746044 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2021 | 2855 | 0.120 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2015 | 122 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 3526 | 0.120 |
Why?
|
| Up-Regulation | 5 | 2023 | 4114 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 719 | 0.110 |
Why?
|
| DNA Helicases | 1 | 2019 | 835 | 0.110 |
Why?
|
| Chromatin | 3 | 2022 | 2896 | 0.110 |
Why?
|
| Purines | 1 | 2017 | 590 | 0.110 |
Why?
|
| Adenine | 1 | 2018 | 976 | 0.110 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 1227 | 0.110 |
Why?
|
| Killer Cells, Natural | 1 | 2022 | 2170 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 1875 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2023 | 12741 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 2678 | 0.100 |
Why?
|
| Oncogenes | 1 | 2017 | 1216 | 0.100 |
Why?
|
| Oncolytic Virotherapy | 1 | 2017 | 505 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2015 | 786 | 0.100 |
Why?
|
| Astrocytes | 2 | 2018 | 1303 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2836 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2021 | 11384 | 0.090 |
Why?
|
| Neoplasms | 1 | 2019 | 21688 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3408 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1695 | 0.080 |
Why?
|
| Immunotherapy | 2 | 2022 | 4594 | 0.080 |
Why?
|
| Methylation | 2 | 2023 | 1075 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2022 | 4258 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2021 | 6137 | 0.080 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2020 | 287 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 2829 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3607 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2017 | 6332 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 2800 | 0.070 |
Why?
|
| Sex Factors | 1 | 2021 | 10279 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2019 | 2954 | 0.070 |
Why?
|
| Self Report | 1 | 2017 | 3589 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1567 | 0.070 |
Why?
|
| Histones | 3 | 2021 | 2552 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5159 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 6931 | 0.060 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2023 | 7 | 0.060 |
Why?
|
| Neoplastic Processes | 1 | 2023 | 35 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2023 | 43 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 1809 | 0.060 |
Why?
|
| Sorting Nexins | 1 | 2023 | 26 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2019 | 2620 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2023 | 178 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 11839 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3475 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2021 | 83 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2021 | 103 | 0.050 |
Why?
|
| Gangliosides | 1 | 2022 | 131 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 183 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13303 | 0.050 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2022 | 146 | 0.050 |
Why?
|
| Neurofibromin 2 | 1 | 2022 | 268 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2022 | 240 | 0.050 |
Why?
|
| RNA Editing | 1 | 2022 | 153 | 0.050 |
Why?
|
| Receptors, Vitronectin | 1 | 2020 | 48 | 0.040 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 248 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2022 | 617 | 0.040 |
Why?
|
| Toluidines | 1 | 2019 | 21 | 0.040 |
Why?
|
| Crotonates | 1 | 2019 | 21 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29068 | 0.040 |
Why?
|
| Permeability | 1 | 2021 | 724 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 2887 | 0.040 |
Why?
|
| RNA Interference | 2 | 2018 | 2842 | 0.040 |
Why?
|
| Hydroxybutyrates | 1 | 2019 | 79 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2019 | 133 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13538 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 415 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2019 | 228 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2022 | 1340 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 6453 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 40503 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 172 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2023 | 766 | 0.040 |
Why?
|
| Ribose-Phosphate Pyrophosphokinase | 1 | 2017 | 8 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2021 | 781 | 0.040 |
Why?
|
| Adult | 3 | 2022 | 214958 | 0.040 |
Why?
|
| Circadian Clocks | 1 | 2019 | 161 | 0.040 |
Why?
|
| Child | 2 | 2022 | 78456 | 0.030 |
Why?
|
| Vero Cells | 1 | 2017 | 479 | 0.030 |
Why?
|
| Heterochromatin | 1 | 2018 | 287 | 0.030 |
Why?
|
| Female | 9 | 2021 | 382109 | 0.030 |
Why?
|
| Cell Death | 1 | 2021 | 1654 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 533 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1883 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 72416 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2019 | 1731 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2019 | 622 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3581 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 2017 | 265 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2017 | 559 | 0.030 |
Why?
|
| Nitriles | 1 | 2019 | 946 | 0.030 |
Why?
|
| Apoptosis | 2 | 2022 | 9421 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 2416 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2021 | 18891 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 918 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1109 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 615 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 2466 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 814 | 0.030 |
Why?
|
| Male | 6 | 2021 | 351093 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2021 | 3722 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1476 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1229 | 0.030 |
Why?
|
| RNA | 1 | 2022 | 2693 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 2662 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 888 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2021 | 2558 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6831 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4576 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 214412 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 2865 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3445 | 0.020 |
Why?
|
| Protein Binding | 1 | 2021 | 9278 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3709 | 0.020 |
Why?
|
| Stem Cells | 1 | 2022 | 3513 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8294 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7580 | 0.020 |
Why?
|
| Metabolomics | 1 | 2017 | 1570 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 12447 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8511 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4558 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9170 | 0.010 |
Why?
|
| Brain | 2 | 2021 | 26596 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9310 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 5607 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2017 | 3742 | 0.010 |
Why?
|
| Genomics | 1 | 2017 | 5694 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11539 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 21529 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 78297 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63661 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 164236 | 0.000 |
Why?
|